Skip to main content
ConductScienceScienceDex

Thomas Dick

NIH Rank #2001
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 14751910Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$2.6M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#2,001
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Thomas Dick. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Thomas Dick as a PI. Multi-PI records show the full award amount for context.

  • 5R01AI132374-09R01
    Discovery of novel lead-target pairs and identification of all-oral bactericidal drug regimens for Mycobacterium abscessus lung disease
    Hackensack University Medical Center
    $872.8K
    award amount
  • 5R01AI184502-02R01
    Shorter and more effective oral regimens for M. abscessus pulmonary disease
    Hackensack University Medical Center
    $857K
    award amount
  • 5R01AI177342-04R01
    Optimization of rifamycins to overcome intrinsic resistance of nontuberculous mycobacteria to improve treatment of NTM lung disease
    Hackensack University Medical Center
    $838.3K
    award amount

Award organization

Organizations that administered FY2026 awards listing Thomas Dick as a PI.

FY2026 award administered by Hackensack University Medical Center (NJ).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Hackensack University Medical Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6909
  5. 2025
    $2M Cumulative Funding
  6. 2025
    $5M Cumulative Funding
  7. 2025
    Entered Top 25% Nationally
    Ranked #2541
  8. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Thomas Dick.

Courtney C Aldrich
Hackensack University Medical Center
3
shared awards
Andrew Nelson
Hackensack University Medical Center
1
shared award
David Alland
Hackensack University Medical Center
1
shared award
David S Perlin
Hackensack University Medical Center
1
shared award
James M Balkovec
Hackensack University Medical Center
1
shared award
Richard H. Ebright
Hackensack University Medical Center
1
shared award
Terry Roemer
Hackensack University Medical Center
1
shared award
Vidmantas Petraitis
Hackensack University Medical Center
1
shared award

Explore further

Find collaborators for Thomas Dick

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →